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Summary 
Background: Trends in mean body mass index (BMI) characterise shifts in the population 
distribution of BMI, and prevalences of underweight, and severe and morbid obesity (BMI ≥ 35 
and 40 kg/m2, respectively) show what proportion of the population are at high risks of adverse 
health outcomes. Our aim was to estimate trends in mean BMI and in prevalences of various BMI 
categories for adults in all countries.  
 
Methods: We reanalysed population-based studies with measured height and weight data in adults 
aged 18 years and older using a consistent protocol. We applied a Bayesian hierarchical model to 
these data to estimate trends from 1975 to 2014 in mean BMI and in the prevalences of BMI < 
18.5 kg/m2 (underweight), 18.5 to <20 kg/m2, 20 to <25 kg/m2, 25 to <30 kg/m2, 30 to <35 kg/m2, 
35 to <40 kg/m2, ≥40 kg/m2 by sex in 200 countries and territories, organised in 21 regions. We 
calculated the posterior probability of meeting the target of halting by 2025 the rise in obesity 
compared to its 2010 levels, if post-2000 trends continue. 
 
Findings: Global age-standardised mean BMI increased from 21.7 kg/m2 (95% credible interval 
21.3-22.1) in 1975 to 24.2 kg/m2 (24.0-24.4) in 2014 in men, and from 22.1 (21.7-22.5) kg/m2 in 
1975 to 24.4 (24.2-24.6) kg/m2 in 2014 in women. Regional mean BMIs in 2014 for men ranged 
from 21.4 kg/m2 in Central Africa and South Asia to 29.2 (28.6-29.8) kg/m2 in Polynesia and 
Micronesia; for women the range was from 21.8 (21.4-22.3) kg/m2 in South Asia to 32.2 (31.5-
32.8) kg/m2 in Polynesia and Micronesia. Over these four decades, global prevalence of 
underweight (BMI <18.5 kg/m2) declined from 13.8% (10.5-17.4) to 8.8% (7.4-10.3) in men and 
from 14.6% (11.6-17.9) to 9.7% (8.3-11.1) in women. South Asia had the highest prevalence of 
underweight in 2014, 23.4% (17.8-29.2) in men and 24.0% (18.9-29.3) in women. Prevalence of 
obesity increased from 3.2% (2.4-4.1) in 1975 to 10.8% (9.7-12.0) in 2014 in men, and from 6.4% 
(5.1-7.8) to 14.9% (13.6-16.1) in women. 2.3% (2.0-2.7) of the world’s adult men and 5.0% (4.4-
5.6) of adult women are severely obese. Morbid obesity is 0.64% (0.46-0.86) among men and 1.6% 
(1.3-1.9) among women. If post-2000 trends continue, the probability of meeting the global obesity 
target is virtually zero. Rather, if these trends continue, by 2025, global obesity prevalence will 
surpass 17% in men and 21% in women; severe obesity will surpass 6% in men and 9% in women. 
 
Interpretation: If current trends continue, the world will not meet the global obesity target, and 
will face an epidemic of severe obesity. Underweight nonetheless remains prevalent in the world’s 
poorest regions, especially in South Asia. 
 
Funding: Wellcome Trust; Grand Challenges Canada   
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Introduction 
High body mass index (BMI) is an important risk factor for cardiovascular and kidney diseases, 
diabetes, some cancers and musculoskeletal conditions.1-7 Concerns about the health and economic 
burden of increasing BMI have led to adiposity being included among the global non-
communicable diseases (NCD) targets, with a target of halting, by 2025, the rise in the prevalence 
of obesity compared to 2010 (i.e., age-standardised prevalence in 2025 is no more than its 2010 
level).8, 9 Information on whether countries are on track to achieve this target is needed to support 
accountability towards the global NCD commitments.10 
 
Two previous studies estimated global trends in the prevalences of overweight and obesity.11-13 
The largest health benefits of weight management are achieved by shifting the population 
distribution of BMI. The only global report on mean BMI, which characterises distributional shifts, 
estimated trends to 2008,11 before the global target was agreed upon. Epidemiological studies have 
also demonstrated substantial risks among people with very high BMI, e.g., ≥35 or ≥40kg/m2 
(referred to as severe and morbid obesity, respectively).14 Being underweight is also associated 
with increased risk of morbidity and mortality (i.e., a so-called J-shaped association) and with 
adverse pregnancy outcomes.4, 6, 15, 16 There are no consistent global estimates of trends in 
underweight, especially for men,17 and in severe and morbid obesity. Finally, there is no 
information on how likely it is for countries to achieve the global obesity target. 
 
We pooled population-based data to estimate trends from 1975 to 2014 in both mean BMI and in 
prevalences of BMI categories, ranging from underweight to morbid obesity. We also estimated 
the probability of achieving the global obesity target. 
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Methods 
Overview 
We estimated trends in mean BMI and prevalences of BMI categories <18.5 kg/m2 (underweight), 
18.5 to <20 kg/m2, 20 to <25 kg/m2, 25 to <30 kg/m2, 30 to <35 kg/m2, 35 to <40 kg/m2, ≥40 kg/m2 
(morbid obesity) from 1975 to 2014 in 200 countries and territories. We report results for these 
categories, as well as for total obesity (BMI ≥30 kg/m2) and severe obesity (BMI ≥35 kg/m2). 
Countries and territories were organised into 21 regions, mostly based on geography and national 
income (Appendix Table 1). The exception was a region consisting of high-income English-
speaking countries because BMI and other cardiometabolic risk factors have similar trends in these 
countries, which can be distinct from other countries in their geographical region. Our analysis 
covered men and women 18 years of age and older, consistent with the Global Monitoring 
Framework for NCDs.8  
 
Our study had two steps, described below. First, we identified, accessed, and reanalysed 
population-based measurement studies of human anthropometry. We then used a statistical model 
to estimate trends for all countries and years. 
 
Data sources 
We used data sources that were representative of a national, subnational, or community population 
and had measured height and weight. We did not use self-reported height and weight because they 
are subject to biases that vary by geography, time, age, sex, and socioeconomic characteristics.18-
20
 Due to these variations, current approaches to correcting self-reported data leave residual bias 
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and error. Our data inclusion and exclusion criteria, listed in Appendix, were designed to ensure 
population representativeness. Our methods for identifying and accessing data are described in 
Appendix. 
 
Statistical methods 
We performed all analyses by sex, because there are differences in BMI levels and trends in 
relation to sex. The statistical method is described in a statistical paper, and in the Appendix of a 
previous empirical paper.21, 22 In summary, the model had a hierarchical structure in which 
estimates for each country and year were informed by its own data, if available, and by data from 
other years in the same country and in other countries, especially those in the same region with 
data for similar time periods. The hierarchical structure shares information to a greater degree 
when data are non-existent or weakly informative (e.g., have a small sample size or, as described 
below, are not national), and to a lesser extent in data-rich countries and regions. 
 
The model incorporated non-linear time trends and age patterns; national versus subnational and 
community representativeness; and whether data covered both rural and urban areas versus only 
one of them. The model included covariates that help predict BMI, including national income 
(natural logarithm of per-person GDP adjusted for inflation and purchasing power), proportion of 
population living in urban areas, and a summary measure of availability of different food types for 
human consumption.23, 24 We also conducted an analysis without the use of covariates and 
compared the estimates with and without covariates. Estimates with and without covariates were 
virtually identical in most countries (Appendix Figure 4) with the exception of a few countries that 
had no data and whose covariates (e.g., national income) differed from those of their region, e.g., 
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Brunei Darussalam, Bermuda, and North Korea. We report estimates for the model with covariates 
because it had significantly better fit to data, as measured by deviance information criterion. 
 
We analysed mean BMI and each of the above prevalences separately. We re-scaled the estimated 
prevalences of different categories so that their sum was 1.0 in each age, sex, country, and year. 
The average scaling factor across draws was 1.05 for men and 1.07 for women, i.e., the sum of the 
separately estimated prevalences was close to 1.0. Estimates for regions and the world were 
calculated as population-weighted averages of the constituent country estimates by age group and 
sex. For presentation, we age-standardised the estimated means and prevalences to the WHO 
reference population,25 by taking weighted averages of age-sex-specific estimates with use of age 
weights from the reference population. We tested how well our statistical model predicts missing 
data as described in the Appendix, which showed that it performed extremely well in estimating 
mean BMI as well as prevalences of BMI categories when data were missing. 
 
We estimated average change in mean and prevalence (absolute change for mean and relative 
change for prevalence) over the 40 years of analysis and report as change per decade. We also 
report the posterior probability (PP) that an estimated increase or decrease represents a truly 
increasing or decreasing trend. In addition, we made separate trend estimates for pre-2000 and 
post-2000 years to assess whether the increasing recognition of adiposity as an “epidemic” in the 
1990s,26 and subsequent public health attention and response,27, 28 may have slowed down its rise. 
We calculated the PP of meeting the global obesity target if post-2000 trends continue. 
 
Role of funding source 
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The funder of the study had no role in study design, data collection, analysis, interpretation, or 
writing of the report. Country and Regional Data Group members, MDC and JB had full access to 
the data in the study and the corresponding author had final responsibility for the decision to submit 
for publication. 
 
Results 
Data availability 
We used 1,698 population-based data sources, with ~19.2 million participants (9.9 million men; 
9.3 million women) aged ≥18 years whose height and weight had been measured, in 186 of 200 
countries for which estimates were made (Appendix Figure 2); these 186 countries covered 99% 
of the world’s population. 159 countries had at least two data sources, which allowed more reliable 
trend estimates. 827 sources (48.7%) were national, 236 (13.9%) were subnational, and the 
remaining 635 (37.4%) were community-based (Appendix Figure 3). Across regions, there were 
between an average of 2.8 data sources per country in Polynesia and Micronesia to 35 per country 
in high-income Asia Pacific. 525 data sources (30.9%) were from years before 1995 and another 
1173 (69.1%) for 1995 and later. 1314 sources had data on men as well as women, 144 only on 
men, and 240 only on women. 
 
Mean BMI (global and regional) 
Global age-standardised mean BMI in men increased from 21.7 kg/m2 (95% CrI 21.3-22.1) in 
1975 to 24.2 kg/m2 (24.0-24.4) in 2014, and in women from 22.1 (21.7-22.5) kg/m2 in 1975 to 
24.4 (24.2-24.6) kg/m2 in 2014 (Figure 1) (PP of being a true rise >0.9999 for both sexes). The 
average rises of 0.63 kg/m2 per decade (0.53-0.73) for men and 0.59 kg/m2 per decade (0.49-0.70) 
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for women are equivalent to the world’s population having become on average >1.5 kg heavier 
each decade.  
 
Regional mean BMI in 2014 for men ranged from 21.4 kg/m2 in Central Africa and South Asia to 
29.2 (28.6-29.8) kg/m2 in Polynesia and Micronesia (Figure 1). For women the range was from 
21.8 (21.4-22.3) kg/m2 in South Asia to 32.2 (31.5-32.8) kg/m2 in Polynesia and Micronesia. Mean 
BMI was also high among men and women in the region comprising of high-income English-
speaking countries, and in women in Southern Africa and in Middle East and North Africa.  
 
The largest rise in men’s BMI occurred in high-income English-speaking countries (1.00 kg/m2 
per decade; PP >0.9999) and for women in Central Latin America (1.27 kg/m2 per decade; PP 
>0.9999). The increase in female BMI was also >1.00 kg/m2 per decade in Melanesia, Polynesia 
and Micronesia, high-income English-speaking countries, South East Asia, Andean Latin America 
and the Caribbean. Due to these trends, in 2014 men and women in high-income English-speaking 
countries had substantially higher BMIs than those in continental Europe, whereas in 1975 their 
BMI had been similar or lower, especially for women (Figure 1). In contrast to these large 
increases, the rise in women’s BMI was <0.2 kg/m2 per decade in Central and South Western 
Europe and high-income Asia-Pacific. 
 
Mean BMI (country level) 
In 1975, age-standardised mean BMI was <19 kg/m2 among men in Timor-Leste, Burundi,  India, 
Ethiopia, Viet Nam, Rwanda, Eritrea and Bangladesh, and 17-18 kg/m2 among women in 
Bangladesh, Nepal, Timor-Leste, Burundi, Cambodia and Viet Nam (Figure 2). In the same year, 
 9 
men and women in Nauru and women in American Samoa already had mean BMIs >30 kg/m2.29, 
30
 By 2014, age-standardised mean BMI had reached >20.0 kg/m2 in men and >20.7 kg/m2 in 
women in every country, with Ethiopia, Eritrea and Timor-Leste having the lowest BMIs for both 
sexes. At the same time, men and women in American Samoa had age-standardised mean BMIs 
of 32.2 (30.5-33.7) and 34.8 (33.2-36.3) kg/m2, respectively, with mean BMI also >30 kg/m2 in 
both sexes in some other islands in Polynesia and Micronesia, and in women in some countries in 
Middle East and North Africa (e.g., Egypt and Kuwait) and the Caribbean.  
 
Trends in men’s BMI over these four decades ranged from virtually flat in Nauru (albeit at a very 
high level), North Korea and a number of countries in sub-Saharan Africa, to an increase of >1.5 
kg/m2 per decade. Similarly, women’s BMI did not change in Bahrain and Nauru (both starting at 
high BMIs), Singapore, Japan, North Korea and a number of European countries, but increased by 
>1.5 kg/m2 per decade in some countries. BMI rose more slowly after the year 2000 than it had in 
the preceding 2.5 decades in Oceania and in most high-income countries for both sexes, and for 
women in most countries in Latin America and the Caribbean (Figure 3). In contrast, the post-
2000 rise was steeper than pre-2000 among men in Central and Eastern Europe, East and Southeast 
Asia, and most countries in Latin America and the Caribbean. In other regions, pre- and post-2000 
increases in BMI were similar or there was a mix of slow-down and acceleration. The standard 
deviation of BMI also increased from 1975 to 2014 (Appendix Figure 5), which contributed to 
increasing the prevalences of people at low and/or high BMI levels, as presented below. 
 
BMI varied more across countries in women (e.g., 14.1 kg/m2, equivalent to ~35 kg heavier in 
American Samoa compared to Timor-Leste) than it did among men (12.1 kg/m2). Although male 
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and female BMIs were correlated across countries, women had higher BMI than men in 141 
countries in 2014 (Appendix Figure 6). There was weak correlation between changes in male and 
female BMI across countries. 
 
Prevalences of BMI categories (global and regional) 
Over these four decades, global age-standardised prevalence of underweight declined from 13.8% 
(10.5-17.4) to 8.8% (7.4-10.3) in men and from 14.6% (11.6-17.9) to 9.7% (8.3-11.1) in women 
(Figure 4). Compared to the fall in underweight, prevalence of obesity increased by a larger amount 
– from 3.2% (2.4-4.1) in 1975 to 10.8% (9.7-12.0) in 2014 in men, and from 6.4% (5.1-7.8) to 
14.9% (13.6-16.1) in women. Prevalence of obesity surpassed that of underweight in 2004 in 
women and in 2011 in men. 2.3% (2.0-2.7) of the world’s adult men and 5.0% (4.4-5.6) of adult 
women are severely obese. Morbid obesity is 0.64% (0.46-0.86) among men and 1.6% (1.3-1.9) 
among women. 
 
Age-standardised underweight prevalence in South Asia, where it is most common, declined from 
>35% in 1975 to ~24% in 2014 in both sexes (Figure 4). Underweight prevalence also remains 
>12% in women and >15% in men in Central and East Africa, despite some declines. At the other 
extreme, >38% of men and >50% of women in Polynesia and Micronesia are obese. Obesity 
prevalence also surpasses 30% among men and women in English-speaking high-income 
countries, and women in Southern Africa and in Middle East and North Africa. 
 
Prevalences of BMI categories (country level) 
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Age-standardised prevalence of underweight in 2014 was less than 1% among men in 68 countries 
and among women in 11 countries (Figure 5). At the other extreme, >20% of men in India, 
Bangladesh, Timor-Leste, Afghanistan, Eritrea and Ethiopia, and a quarter or more of women in 
Bangladesh and India are still underweight. In 1975, the proportion had been as high as 37% in 
Indian and Bangladeshi women.  
 
In 136 of 200 countries, more men are now obese than underweight; in 113 of these, more are 
severely obese than underweight. For women, obesity surpasses underweight in 165 countries and 
severe obesity surpasses underweight in 135. Obesity prevalence was <1% among men in Burundi 
and Timor-Leste and between 1% and 2% in another 15 countries in Central, East and West Africa 
and in South and Southeast Asia. The lowest prevalences in women were in Timor-Leste, Japan, 
Viet Nam, North Korea, Cambodia, Lao PDR and Bangladesh all <5%. At the other extreme, 
>45% of men in 6 islands in Polynesia and Micronesia, and >50% of women in 11 such island 
nations were obese. Women in a number of Caribbean and Middle Eastern countries had obesity 
prevalences of 40% to 50%. Severe obesity surpassed 20% in men and 30% in women in some 
Polynesian and Micronesian islands, reaching 33.4% (23.6-43.5) in American Samoa in 2014. 
Over 15% of women in Nauru and American Samoa were morbidly obese. 
 
Number of underweight, obese and severely obese people 
The above prevalences translate to 266 (240-295) million obese men and 375 (344-407) million 
obese women in the world in 2014, compared to 34 (26-44) million and 71 (57-87) million in 1975 
(Figure 6). 58 (49-68) million of these men and 126 (112-141) million of these women are severely 
obese. 18.4% of the world’s obese adults (118 million) live in English-speaking high-income 
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countries, followed by 14.5% (93 million) in East Asia and 12.4% (79 million) in Middle East and 
North Africa. English-speaking high-income countries house an even larger share of the world’s 
severely obese people (27.1%; 50 million), followed by 13.9% (26 million) in Middle East and 
North Africa.  
 
Countries where large numbers of underweight people lived in 1975 as well as in 2014 were mostly 
large countries in Asia and sub-Saharan Africa, with an increasing share of underweight people 
living in South Asia over time (Figure 7). In contrast to this stability of underweight geography, 
countries with the largest number of obese and severely obese people changed over these four 
decades, with more middle-income countries joining the USA, especially for women. More obese 
men and women now live in China than in the USA, and even for severe obesity China moved 
from 60th place for men and 41st place for women in 1975, to 2nd rank for both men and women in 
2014. Nonetheless, more than one in four severely obese men and almost one in five severely obese 
women in the world are still from the USA. 
 
Progress towards the global target 
If post-2000 trends continue, the probability of meeting the global obesity target is less than 50% 
in every country, with Nauru having the highest probability of ~45% (Appendix Figure 7). With 
an obesity prevalence at >45% for men and >55% for women in Nauru, this is not a public health 
achievement. The probability of achieving the target is <10% among men in 194 countries and 
women in 174 countries. At the global level, the probability of meeting the target is virtually zero. 
Rather, if current trends continue, by 2025, global obesity prevalence will surpass 17% in men and 
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21% in women; and severe obesity will surpass 9% in women, and will be larger than the projected 
prevalence of underweight. 
 
Discussion 
Over the past four decades, we have transitioned from a world in which underweight prevalence 
was more than double that of obesity, to one in which more people are obese than underweight – 
globally as well as in all regions except parts of sub-Saharan Africa and Asia. The rate of increase 
in BMI since 2000 has been slower than the preceding decades in high-income countries, where 
adiposity became an explicit public health concern around this time,27, 28 and in some middle-
income countries; BMI, however, rose faster in some other regions such that the global rise in BMI 
has not slowed. If recent trends continue, not only will the world not meet the global target for 
halting the rise in obesity, but also severe obesity will surpass underweight among women by 2025. 
Underweight nonetheless remains a public health problem in South Asia and Central and East 
Africa.  
 
We estimated a slightly larger rise in mean BMI since 1980 than Finucane et al,11 especially for 
men, because our estimates for 1980 were lower, globally and in most regions. This may be 
because our study included substantially more data, from a larger number of countries. Our global 
estimates of overweight prevalence are similar to those reported by Stevens et al13 for 2008 and by 
Ng et al for 2013;12 our estimates for obesity for the same years are slightly lower than those of 
Stevens et al and slightly higher than those of Ng et al. Further, we estimated a lower prevalence 
of obesity for 1980 than Ng et al had, which means we attribute a larger role to the rise over the 
past few decades for the current extent of obesity. Differences between our study and Ng et al were 
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greater at the regional level, e.g., for obesity among men in South Asia and Central, East and West 
Africa, where our estimates of obesity prevalence are less than half of those by Ng et al. None of 
these previous works had estimated underweight or severe and morbid obesity, which are 
important clinical and public health outcomes.  
 
The strengths of our study include its unique scope of making consistent estimates of mean BMI 
as well as the prevalences of all BMI categories with clinical and public health relevance – 
including the first-ever estimates of underweight and severe and morbid obesity. This helped 
reveal the details of underweight to overweight/obesity transition throughout the world. We also 
reported the probability that each country will meet the global obesity target. We put great 
emphasis on data quality and used only population-based data that had measured height and 
weight, to avoid the bias in self-reported data. Characteristics and quality of data sources were 
verified through repeated checks by Collaborating Group members. Data were analysed according 
to a common protocol to obtain the required mean and prevalences by age and sex, which in turn 
minimised reliance on models for filling such gaps, as done in previous studies.11-13 Finally, we 
pooled data using a statistical model designed to take into account the epidemiological features of 
outcomes such as BMI, and one that used all available data while giving more weight to national 
data than subnational and community studies.  
 
Despite our efforts in identifying and accessing country-level data, some countries had fewer data 
sources, especially those in Polynesia and Micronesia, the Caribbean and Central Asia. In addition, 
only 42% of sources included people older than 70 years. Given ageing trends throughout the 
world, older people should be included in health and nutrition surveys, which have traditionally 
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focused on childbearing ages. Even measured height and weight data can have error depending on 
how closely measurement protocols are followed. Although data held by Collaborating Group 
members were analysed to provide all needed details by age group and BMI level, individual 
participant data could not be accessed for 19.4% of data used in our analysis, hence conversions 
across categories were still needed – the conversion regressions nonetheless had high predictive 
accuracy (Appendix Table 3). Estimating prevalences for a complete set of BMI categories is a 
novel component of our work, but the uncertainty intervals for BMI ≥30 kg/m2 and BMI ≥35 
kg/m2, which span more than one of the analysed categories, may be affected by the fact that we 
combined posterior distributions across Bayesian models. We did not estimate trends in measures 
of adiposity other than BMI, such as waist circumference and waist-to-hip ratio, as these are only 
measured in recent surveys. A systematic review of epidemiological studies found that, taken 
together, these studies do not show that any of the measures of adiposity had “superior 
discriminatory capability” in terms of risk of adverse cardiometabolic outcomes; any observed 
difference was “too small to be of any clinical relevance”.31 We did not analyse children and 
adolescents for two reasons. First, because childhood and adolescence is a period of rapid growth, 
BMI cut-offs used to define under/over-weight and obesity for children and adolescents are 
different from those for adults, and vary by age and sex.32 Second, time trends in children’s and 
adolescents’ obesity are different from those of adults.33 Finally, the global obesity target does not 
penalise a situation in which high prevalence of obesity persists in a country, as is the case in 
Nauru for example.  
 
There are a number of implications to our results. First, the global focus on the obesity epidemic 
has largely overshadowed the persistence of underweight in some countries. Our results 
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demonstrate the need to address the remaining underweight problem, which will reduce risks to 
pregnant women and their newborn infants,15 mortality from tuberculosis and other respiratory 
diseases,34 and possibly all-cause mortality for which there is a J-shaped association.2, 3 Achieving 
this requires social and food policies that enhance food security in poor households, but avoid 
overconsumption of processed carbohydrates and other unhealthy foods. Second, although 
adiposity has been consistently shown to be an independent risk factor for a number of NCDs in 
individual-level epidemiological studies, at the population level, the effect of rising BMI on the 
course of mortality decline has so far been modest in high-income countries,35, 36 possibly because 
pharmacological treatment has helped lower blood pressure and serum cholesterol and manage 
diabetes complications which are mediators of the effects of BMI on cardiovascular diseases. In 
low-income countries, where health systems might not have the capacity to identify and treat 
hypertension, dyslipidaemia and diabetes, adiposity might have larger impact on population health. 
Further, we have shown that some high-income and middle-income regions are now facing an 
epidemic of severe obesity. Even antihypertensive medicines, statins and glucose lowering drugs 
will not be able to fully address the hazards of such high BMI levels,7 and bariatric surgery may 
be the most effective intervention for weight loss and disease prevention and remission.37 
However, long-term health outcomes of bariatric surgery are largely unknown and it is not 
accessible to most people in low- and middle-income countries due to financial and health systems 
barriers. 
 
Current interventions and policies have not been able to stop the rise in BMI in most countries.38-
40
 The global NCD target on obesity, although ambitious in the light of past trends, has engendered 
a new look at policies that may slow down and stop the worldwide rise in BMI.40-42 To avoid an 
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epidemic of severe obesity, the next step must be to implement these policies, and to systematically 
evaluate their impact.43  
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Research in Context 
Evidence before this study 
We searched Medline (via PubMed) using the search terms “body size”[mh:noexp] OR “body 
height”[mh:noexp] OR “body weight”[mh:noexp] OR “birth weight”[mh:noexp] OR 
“overweight”[mh:noexp] OR “obesity”[mh] OR “thinness”[mh:noexp] OR “Waist-Hip 
Ratio”[mh:noexp] or “Waist Circumference”[mh:noexp] or “body mass index” [mh:noexp]) AND 
(“Humans”[mh]) AND(“1950”[PDAT] : “2013”[PDAT]) AND (“Health Surveys”[mh] OR 
“Epidemiological Monitoring”[mh] OR “Prevalence”[mh]) NOT Comment[ptyp] NOT Case 
Reports[ptyp]. Articles were screened according to the inclusion and exclusion criteria described 
in the Appendix.  
 
The only study on trends in mean BMI,11 which characterises shifts in the population distribution 
of BMI, reported trends to 2008 before the global target on obesity was agreed upon, and there are 
no recent data. Two previous studies estimated global trends in the prevalences of overweight and 
obesity.11-13 Neither study reported trends in underweight, which is associated with increased risk 
of morbidity, mortality and adverse pregnancy outcomes, and in high levels of BMI, e.g., ≥35 or 
≥40kg/m2, which are associated with substantial risks of many NCDs.  
 
Added value of this study 
This study provides the longest and most complete picture of trends in adult BMI including, for 
the first time, in underweight and severe and morbid obesity that are of enormous clinical and 
public health interest. We were able to robustly depict this rich picture by re-analysing and pooling 
hundreds of population-based sources with actual measurements of height and weight according 
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to a common protocol. We also systematically projected recent trends into the future, and assessed 
the probability of achieving the global obesity target.  
 
Implications of all the available evidence 
The world has transitioned from an era when underweight prevalence was more than double that 
of obesity, to one in which more people are obese than underweight. Underweight however 
remains a public health problem in the world’s poorest regions, namely South Asia and Central 
and East Africa. If current trends continue, the world not only will not meet the global obesity 
target, but also severe obesity will surpass underweight among women by 2025. 
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of Adelaide, Australia)*; Wichai Aekplakorn (Mahidol University, Thailand)*; Carlos A Aguilar-
Salinas (Instituto Nacional de Ciencias Médicas y Nutricion, Mexico)*; Alireza Ahmadvand (Non-
Communicable Diseases Research Center, Iran)*; Wolfgang Ahrens (Leibniz Institute for 
Prevention Research and Epidemiology - BIPS, Germany)*; Mohamed M Ali (World Health 
Organization Regional Office for the Eastern Mediterranean, Egypt)*; Ala'a Alkerwi 
(Luxembourg Health Institute, Luxembourg)*; Mar Alvarez-Pedrerol (Centre for Research in 
Environmental Epidemiology, Spain)*; Eman Aly (World Health Organization Regional Office 
for the Eastern Mediterranean, Egypt)*; Philippe Amouyel (Lille University and Hospital, 
France)*; Antoinette Amuzu (London School of Hygiene & Tropical Medicine, UK)*; Lars Bo 
Andersen (University of Southern Denmark, Denmark)*; Sigmund A Anderssen (Norwegian 
School of Sport Sciences, Norway)*; Dolores S Andrade (Universidad de Cuenca, Ecuador)*; 
Ranjit Mohan Anjana (Madras Diabetes Research Foundation, India)*; Hajer Aounallah-Skhiri 
(National Institute of Public Health, Tunisia)*; Inger Ariansen (Norwegian Institute of Public 
Health, Norway)*; Tahir Aris (Ministry of Health, Malaysia)*; Nimmathota Arlappa (Indian 
Council of Medical Research, India)*; Dominique Arveiler (Strasbourg University and Hospital, 
France)*; Felix K Assah (University of Yaoundé 1, Cameroon)*; Mária Avdicová (Regional 
Authority of Public Health, Banska Bystrica, Slovakia)*; Fereidoun Azizi (Shahid Beheshti 
University of Medical Sciences, Iran)*; Bontha V Babu (Indian Council of Medical Research, 
India)*; Nagalla Balakrishna (Indian Council of Medical Research, India)*; Piotr Bandosz 
(Medical University of Gdansk, Poland)*; José R Banegas (Universidad Autónoma de Madrid, 
Spain)*; Carlo M Barbagallo (University of Palermo, Italy)*; Alberto Barceló (Pan American 
Health Organization, USA)*; Amina Barkat (Université Mohammed V de Rabat, Morocco)*; 
Mauro V Barros (University of Pernambuco, Brazil)*; Iqbal Bata (Dalhousie University, 
 22 
Canada)*; Anwar M Batieha (Jordan University of Science and Technology, Jordan)*; Rosangela 
L Batista (Federal University of Maranhao, Brazil)*; Louise A Baur (University of Sydney, 
Australia)*; Robert Beaglehole (University of Auckland, New Zealand)*; Habiba Ben Romdhane 
(Faculty of Medicine of Tunis, Tunisia)*; Mikhail Benet (University Medical Science, Cuba)*; 
Antonio Bernabe-Ortiz (Universidad Peruana Cayetano Heredia, Peru)*; Gailute Bernotiene 
(Lithuanian University of Health Sciences, Lithuania)*; Heloisa Bettiol (University of São Paulo, 
Brazil)*; Aroor Bhagyalaxmi (B. J. Medical College, India)*; Sumit Bharadwaj (Chirayu Medical 
College, India)*; Santosh K Bhargava (Sunder Lal Jain Hospital, India)*; Zaid Bhatti (The Aga 
Khan University, Pakistan)*; Zulfiqar A Bhutta (The Aga Khan University, Pakistan)*; 
HongSheng Bi (Shandong University of Traditional Chinese Medicine, China)*; Yufang Bi 
(Shanghai Jiao-Tong University School of Medicine, China)*; Peter Bjerregaard (University of 
Southern Denmark, Denmark; University of Greenland, Greenland)*; Espen Bjertness (University 
of Oslo, Norway)*; Marius B Bjertness (University of Oslo, Norway)*; Cecilia Björkelund 
(University of Gothenburg, Sweden)*; Margaret Blake (NatCen Social Research, UK)*; Anneke 
Blokstra (National Institute for Public Health and the Environment, The Netherlands)*; Simona 
Bo (University of Turin, Italy)*; Martin Bobak (University College London, UK)*; Lynne M 
Boddy (Liverpool John Moores University, UK)*; Bernhard O Boehm (Nanyang Technological 
University, Singapore)*; Heiner Boeing (German Institute of Human Nutrition, Germany)*; 
Carlos P Boissonnet (CEMIC, Argentina)*; Vanina Bongard (Toulouse University School of 
Medicine, France)*; Pascal Bovet (Ministry of Health, Seychelles; University of Lausanne, 
Switzerland)*; Lutgart Braeckman (Ghent University, Belgium)*; Marjolijn CE Bragt 
(FrieslandCampina, Singapore)*; Imperia Brajkovich (Universidad Central de Venezuela, 
Venezuela)*; Francesco Branca (World Health Organization, Switzerland)*; Juergen 
 23 
Breckenkamp (Bielefeld University, Germany)*; Hermann Brenner (German Cancer Research 
Center, Germany)*; Lizzy M Brewster (University of Amsterdam, The Netherlands)*; Garry R 
Brian (The Fred Hollows Foundation New Zealand, New Zealand)*; Graziella Bruno (University 
of Turin, Italy)*; H.B(as) Bueno-de-Mesquita (National Institute for Public Health and the 
Environment, The Netherlands)*; Anna Bugge (University of Southern Denmark, Denmark)*; 
Con Burns (Cork Institute of Technology, Ireland)*; Antonio Cabrera de León (Canarian Health 
Service, Spain)*; Joseph Cacciottolo (University of Malta, Malta)*; Tilema Cama (Ministry of 
Health, Tonga)*; Christine Cameron (Canadian Fitness and Lifestyle Research Institute, 
Canada)*; José Camolas (Hospital Santa Maria, CHLN, Portugal)*; Günay Can (Istanbul 
University, Turkey)*; Ana Paula C Cândido (Universidade Federal de Juiz de Fora, Brazil)*; 
Vincenzo Capuano (Cardiologia di Mercato S. Severino, Italy)*; Viviane C Cardoso (University 
of São Paulo, Brazil)*; Maria J Carvalho (University of Porto, Portugal)*; Felipe F Casanueva 
(Santiago de Compostela University, Spain)*; Juan-Pablo Casas (University College London, 
UK)*; Carmelo A Caserta (Associazione Calabrese di Epatologia, Italy)*; Katia Castetbon (French 
Institute for Health Surveillance, France)*; Snehalatha Chamukuttan (India Diabetes Research 
Foundation, India)*; Angelique W Chan (Duke-NUS Graduate Medical School, Singapore)*; 
Queenie Chan (Imperial College London, UK)*; Himanshu K Chaturvedi (National Institute of 
Medical Statistics, India)*; Nishi Chaturvedi (University College London, UK)*; Chien-Jen Chen 
(Academia Sinica, Taiwan)*; Fangfang Chen (Capital Institute of Pediatrics, China)*; Huashuai 
Chen (Duke University, USA)*; Shuohua Chen (Kailuan General Hospital, China)*; Zhengming 
Chen (University of Oxford, UK)*; Ching-Yu Cheng (Duke-NUS Graduate Medical School, 
Singapore)*; Angela Chetrit (The Gertner Institute for Epidemiology and Health Policy Research, 
Israel)*; Arnaud Chiolero (Lausanne University Hospital, Switzerland)*; Shu-Ti Chiou (Ministry 
 24 
of Health and Welfare, Taiwan)*; Adela Chirita-Emandi (University of Medicine and Pharmacy 
"Victor Babes", Romania)*; Yumi Cho (Korea Centers for Disease Control and Prevention, South 
Korea)*; Kaare Christensen (University of Southern Denmark, Denmark)*; Jerzy Chudek 
(Medical University of Silesia, Poland)*; Renata Cifkova (Charles University in Prague, Czech 
Republic)*; Frank Claessens (Katholieke Universiteit Leuven, Belgium)*; Els Clays (Ghent 
University, Belgium)*; Hans Concin (Agency for Preventive and Social Medicine, Austria)*; 
Cyrus Cooper (University of Southampton, UK)*; Rachel Cooper (University College London, 
UK)*; Tara C Coppinger (Cork Institute of Technology, Ireland)*; Simona Costanzo (IRCCS 
Istituto Neurologico Mediterraneo Neuromed, Italy)*; Dominique Cottel (Institut Pasteur de Lille, 
France)*; Chris Cowell (Westmead University of Sydney, Australia)*; Cora L Craig (Canadian 
Fitness and Lifestyle Research Institute, Canada)*; Ana B Crujeiras (CIBEROBN, Spain)*; 
Graziella D'Arrigo (National Council of Research, Italy)*; Eleonora d'Orsi (Federal University of 
Santa Catarina, Brazil)*; Jean Dallongeville (Institut Pasteur de Lille, France)*; Albertino 
Damasceno (Eduardo Mondlane University, Mozambique)*; Camilla T Damsgaard (University of 
Copenhagen, Denmark)*; Goodarz Danaei (Harvard T.H. Chan School of Public Health, USA)*; 
Rachel Dankner (The Gertner Institute for Epidemiology and Health Policy Research, Israel)*; 
Luc Dauchet (Lille University Hospital, France)*; Guy De Backer (Ghent University, Belgium)*; 
Dirk De Bacquer (Ghent University, Belgium)*; Giovanni de Gaetano (IRCCS Istituto 
Neurologico Mediterraneo Neuromed, Italy)*; Stefaan De Henauw (Ghent University, Belgium)*; 
Delphine De Smedt (Ghent University, Belgium)*; Mohan Deepa (Madras Diabetes Research 
Foundation, India)*; Alexander D Deev (Moscow Lomonosov State University, Russia)*; Abbas 
Dehghan (Erasmus Medical Center Rotterdam, The Netherlands)*; Hélène Delisle (University of 
Montreal, Canada)*; Francis Delpeuch (Institut de Recherche pour le Développement, France)*; 
 25 
Klodian Dhana (Erasmus Medical Center Rotterdam, The Netherlands)*; Wan Mohamud Dhana 
(Institute for Medical Research, Malaysia)*; Augusto F Di Castelnuovo (IRCCS Istituto 
Neurologico Mediterraneo Neuromed, Italy)*; Juvenal Soares Dias-da-Costa (Universidade do 
Vale do Rio dos Sinos, Brazil)*; Alejandro Diaz (National Council of Scientific and Technical 
Research, Argentina)*; Shirin Djalalinia (Non-Communicable Diseases Research Center, Iran)*; 
Ha TP Do (National Institute of Nutrition, Vietnam)*; Annette J Dobson (University of 
Queensland, Australia)*; Chiara Donfrancesco (Istituto Superiore di Sanità, Italy)*; Angela 
Döring (Helmholtz Zentrum München, Germany)*; Kouamelan Doua (Ministère de la Santé et de 
la Lutte Contre le Sida, Côte d’Ivoire)*; Wojciech Drygas (The Cardinal Wyszynski Institute of 
Cardiology, Poland)*; Eruke E Egbagbe (University of Benin College of Medical Sciences, 
Nigeria)*; Robert Eggertsen (University of Gothenburg, Sweden)*; Ulf Ekelund (Norwegian 
School of Sport Sciences, Norway)*; Jalila El Ati (National Institute of Nutrition and Food 
Technology, Tunisia)*; Paul Elliott (Imperial College London, UK)*; Reina Engle-Stone 
(University of California Davis, USA)*; Rajiv T Erasmus (University of Stellenbosch, South 
Africa)*; Cihangir Erem (Karadeniz Technical University, Turkey)*; Louise Eriksen (University 
of Southern Denmark, Denmark)*; Jorge Escobedo-de la Peña (Instituto Mexicano del Seguro 
Social, Mexico)*; Alun Evans (The Queen's University of Belfast, UK)*; David Faeh (University 
of Zurich, Switzerland)*; Caroline H Fall (University of Southampton, UK)*; Farshad Farzadfar 
(Non-Communicable Diseases Research Center, Iran)*; Francisco J Felix-Redondo (Centro de 
Salud Villanueva Norte, Spain)*; Trevor S Ferguson (The University of the West Indies, 
Jamaica)*; Daniel Fernández-Bergés (Hospital Don Benito-Villanueva de la Serena, Spain)*; 
Daniel Ferrante (Ministry of Health, Argentina)*; Marika Ferrari (Council  for Agricultural 
Research and Economics, Italy)*; Catterina Ferreccio (Pontificia Universidad Católica de Chile, 
 26 
Chile)*; Jean Ferrieres (Toulouse University School of Medicine, France)*; Joseph D Finn 
(University of Manchester, UK)*; Krista Fischer (University of Tartu, Estonia)*; Eric Monterubio 
Flores (Instituto Nacional de Salud Pública, Mexico)*; Bernhard Föger (Agency for Preventive 
and Social Medicine, Austria)*; Leng Huat Foo (Universiti Sains Malaysia, Malaysia)*; Ann-Sofie 
Forslund (Department of Health Science, Sweden)*; Stephen P Fortmann (Stanford University, 
USA)*; Heba M Fouad (WHO Regional Office for the Eastern Mediterranean, Egypt)*; Damian 
K Francis (The University of the West Indies, Jamaica)*; Maria do Carmo Franco (Federal 
University of São Paulo, Brazil)*; Oscar H Franco (Erasmus Medical Center Rotterdam, The 
Netherlands)*; Guillermo Frontera (Hospital Universitario Son Espases, Spain)*; Flavio D Fuchs 
(Hospital de Clinicas de Porto Alegre, Brazil)*; Sandra C Fuchs (Universidade Federal do Rio 
Grande do Sul, Brazil)*; Yuki Fujita (Kinki University Faculty of Medicine, Japan)*; Takuro 
Furusawa (Kyoto University, Japan)*; Zbigniew Gaciong (Medical University of Warsaw, 
Poland)*; Mihai Gafencu (University of Medicine and Pharmacy "Victor Babes", Romania)*; 
Andrzej Galbarczyk (Jagiellonian University Medical College, Poland)*; Dickman Gareta 
(University of KwaZulu-Natal, South Africa)*; Sarah P Garnett (University of Sydney, 
Australia)*; Jean-Michel Gaspoz (Geneva University Hospitals, Switzerland)*; Magda Gasull 
(CIBER en Epidemiología y Salud Pública, Spain)*; Louise Gates (Australian Bureau of Statistics, 
Australia)*; Johanna M Geleijnse (Wageningen University, The Netherlands)*; Anoosheh 
Ghasemian (Non-Communicable Diseases Research Center, Iran)*; Simona Giampaoli (Istituto 
Superiore di Sanità, Italy)*; Francesco Gianfagna (University of Insubria, Italy)*; Jonathan 
Giovannelli (Lille University Hospital, France)*; Rebecca A Goldsmith (Nutrition Department, 
Ministry of Health, Israel)*; Marcela Gonzalez Gross (Universidad Politécnica de Madrid, 
Spain)*; Juan P González Rivas (The Andes Clinic of Cardio-Metabolic Studies, Venezuela)*; 
 27 
Mariano Bonet Gorbea (National Institute of Hygiene, Epidemiology and Microbiology, Cuba)*; 
Frederic Gottrand (Université de Lille 2, France)*; Sidsel Graff-Iversen (Norwegian Institute of 
Public Health, Norway)*; Dušan Grafnetter (Institute for clinical and experimental medicine, 
Czech Republic)*; Aneta Grajda (The Children's Memorial Health Institute, Poland)*; Maria G 
Grammatikopoulou (Alexander Technological Educational Institute, Greece)*; Ronald D Gregor 
(Dalhousie University, Canada)*; Tomasz Grodzicki (Jagiellonian University Medical College, 
Poland)*; Anders Grøntved (University of Southern Denmark, Denmark)*; Grabriella Gruden 
(University of Turin, Italy)*; Vera Grujic (Institute of Public Health of Vojvodina, Serbia)*; 
Dongfeng Gu (National Center of Cardiovascular Diseases, China)*; Ong Peng Guan (Singapore 
Eye Research Institute, Singapore)*; Vilmundur Gudnason (Icelandic Heart Association, 
Iceland)*; Ramiro Guerrero (Universidad Icesi, Colombia)*; Idris Guessous (Geneva University 
Hospitals, Switzerland)*; Andre L Guimaraes (State University of Montes Claros, Brazil)*; Martin 
C Gulliford (King's College London, UK)*; Johanna Gunnlaugsdottir (Icelandic Heart 
Association, Iceland)*; Marc Gunter (Imperial College London, UK)*; Xiu H Guo (Capital 
Medical University, China)*; Yin Guo (Capital Medical University, China)*; Prakash C Gupta 
(Sekhsaria Institute for Public Health, India)*; Oye Gureje (University of Ibadan, Nigeria)*; Beata 
Gurzkowska (The Children's Memorial Health Institute, Poland)*; Laura Gutierrez (Institute for 
Clinical Effectiveness and Health Policy, Argentina)*; Felix Gutzwiller (University of Zurich, 
Switzerland)*; Jytte Halkjær (Danish Cancer Society Research Centre, Denmark)*; Rebecca 
Hardy (University College London, UK)*; Rachakulla Hari Kumar (Indian Council of Medical 
Research, India)*; Alison J Hayes (University of Sydney, Australia)*; Jiang He (Tulane 
University, USA)*; Marleen Elisabeth Hendriks (University of Amsterdam, The Netherlands)*; 
Leticia Hernandez Cadena (National Institute of Public Health, Mexico)*; Ramin Heshmat 
 28 
(Tehran University of Medical Sciences, Iran)*; Ilpo Tapani Hihtaniemi (Imperial College 
London, UK)*; Sai Yin Ho (University of Hong Kong, China)*; Suzanne C Ho (The Chinese 
University of Hong Kong, Hong Kong)*; Michael Hobbs (University of Western Australia, 
Australia)*; Albert Hofman (Erasmus Medical Center Rotterdam, The Netherlands)*; Claudia M 
Hormiga (Fundación Oftalmológica de Santander, Colombia)*; Bernardo L Horta (Universidade 
Federal de Pelotas, Brazil)*; Leila Houti (University of Oran 1, Algeria)*; Thein Thein Htay 
(Ministry of Health, Myanmar)*; Aung Soe Htet (University of Oslo, Norway)*; Maung Maung 
Than Htike (Ministry of Health, Myanmar)*; Yonghua HU (Peking University Health Science 
Center, China)*; Abdullatif S Hussieni (Birzeit University, Palestine)*; Chinh Nguyen Huu 
(National Institute of Nutrition, Vietnam)*; Inge Huybrechts (International Agency for Research 
on Cancer, France)*; Nahla Hwalla (American University of Beirut, Lebanon)*; Licia Iacoviello 
(IRCCS Istituto Neurologico Mediterraneo Neuromed, Italy)*; Anna G Iannone (Cardiologia di 
Mercato S. Severino, Italy)*; Mohsen M Ibrahim (Cairo University, Egypt)*; Nayu Ikeda 
(National Institute of Health and Nutrition, Japan)*; M Arfan Ikram (Erasmus Medical Center 
Rotterdam, The Netherlands)*; Vilma E Irazola (Institute for Clinical Effectiveness and Health 
Policy, Argentina)*; Muhammad Islam (Aga Khan University, Pakistan)*; Masanori Iwasaki 
(Niigata University, Japan)*; Rod T Jackson (University of Auckland, New Zealand)*; Jeremy M 
Jacobs (Hadassah University Medical Center, Israel)*; Tazeen Jafar (Aga Khan University, 
Singapore)*; Kazi M Jamil (Kuwait Institute for Scientific Research, Kuwait)*; Konrad Jamrozik 
(University of Adelaide, Australia; deceased)*; Grazyna Jasienska (Jagiellonian University 
Medical College, Poland)*; Chao Qiang Jiang (University of Hong Kong, China)*; Michel Joffres 
(Simon Fraser University, Canada)*; Jost B Jonas (Ruprecht-Karls-University of Heidelberg, 
Germany)*; Torben Jørgensen (Research Centre for Prevention and Health, Denmark)*; Pradeep 
 29 
Joshi (World Health Organization Country Office, India)*; Anne Juolevi (National Institute for 
Health and Welfare, Finland)*; Gregor Jurak (University of Ljubljana, Slovenia)*; Vesna Jureša 
(University of Zagreb, Croatia)*; Rudolf Kaaks (German Cancer Research Center, Germany)*; 
Anthony Kafatos (University of Crete, Greece)*; Ofra Kalter-Leibovici (The Gertner Institute for 
Epidemiology and Health Policy Research, Israel)*; Efthymios Kapantais (Hellenic Medical 
Association for Obesity, Greece)*; Amir Kasaeian (Non-Communicable Diseases Research 
Center, Iran)*; Joanne Katz (Johns Hopkins Bloomberg School of Public Health, USA)*; 
Prabhdeep Kaur (National Institute of Epidemiology, India)*; Maryam Kavousi (Erasmus Medical 
Center Rotterdam, The Netherlands)*; Ulrich Keil (University of Münster, Germany)*; Lital 
Keinan Boker (University of Haifa, Israel)*; Roya Kelishadi (Isfahan University of Medical 
Sciences, Iran)*; Han HCG Kemper (Vu Medical University, The Netherlands)*; Andre P Kengne 
(South African Medical Research Council, South Africa)*; Mathilde Kersting (Research Institute 
of Child Nutrition (FKE), Germany)*; Timothy Key (University of Oxford, UK)*; Yousef Saleh 
Khader (Jordan University of Science and Technology, Jordan)*; Davood Khalili (Shahid Beheshti 
University of Medical Sciences, Iran)*; Young-Ho Khang (Seoul National University, South 
Korea)*; Kay-Tee H Khaw (University of Cambridge, UK)*; Ilse MSL Khouw 
(FrieslandCampina, Singapore)*; Stefan Kiechl (Medical University Innsbruck, Austria)*; Japhet 
Killewo (Muhimbili University of Health and Allied Sciences, Tanzania)*; Jeongseon Kim 
(National Cancer Center, South Korea)*; Yutaka Kiyohara (Kyushu University, Japan)*; Jeannette 
Klimont (Statistics Austria, Austria)*; Elin Kolle (Norwegian School of Sport Sciences, 
Norway)*; Patrick Kolsteren (Institute of Tropical Medicine, Belgium)*; Paul Korrovits (Tartu 
University Clinics, Estonia)*; Seppo Koskinen (National Institute for Health and Welfare, 
Finland)*; Katsuyasu Kouda (Kinki University Faculty of Medicine, Japan)*; Slawomir Koziel 
 30 
(Polish Academy of Sciences Anthropology Unit in Wroclaw, Poland)*; Wolfgang Kratzer 
(University Hospital Ulm, Germany)*; Steinar Krokstad (Norwegian University of Science and 
Technology, Norway)*; Daan Kromhout (Wageningen University, The Netherlands)*; Herculina 
S Kruger (North-West University, South Africa)*; Krzysztof Kula (Medical University of Lodz, 
Poland)*; Zbigniew Kulaga (The Children's Memorial Health Institute, Poland)*; R Krishna 
Kumar (Amrita Institute of Medical Sciences, India)*; Yadlapalli S Kusuma (All India Institute of 
Medical Sciences, India)*; Kari Kuulasmaa (National Institute for Health and Welfare, Finland)*; 
Catherine Kyobutungi (African Population and Health Research Center, Kenya)*; Fatima Zahra 
laamiri (Université Mohammed V de Rabat, Morocco)*; Tiina Laatikainen (National Institute for 
Health and Welfare, Finland)*; Carl Lachat (Ghent University, Belgium)*; Youcef Laid (National 
Institute of Public Health of Algeria, Algeria)*; Tai Hing Lam (University of Hong Kong, China)*; 
Orlando Landrove (Ministerio de Salud Pública, Cuba)*; Vera Lanska (Institute for Clinical and 
Experimental Medicine, Czech Republic)*; Georg Lappas (Sahlgrenska Academy, Sweden)*; 
Lars E Laugsand (Norwegian University of Science and Technology, Norway)*; Avula Laxmaiah 
(Indian Council of Medical Research, India)*; Khanh Le Nguyen Bao (National Institute of 
Nutrition, Vietnam)*; Tuyen D Le (National Institute of Nutrition, Vietnam)*; Catherine Leclercq 
(Food and Agriculture Organization, Italy)*; Jeannette Lee (National University of Singapore, 
Singapore)*; Jeonghee Lee (National Cancer Center, South Korea)*; Terho Lehtimäki (Tampere 
University Hospital, Finland)*; Rampal Lekhraj (Universiti Putra Malaysia, Malaysia)*; Luz M 
León-Muñoz (Universidad Autónoma de Madrid, Spain)*; Yanping Li (Harvard T.H. Chan School 
of Public Health, USA)*; Wei-Yen Lim (National University of Singapore, Singapore)*; M 
Fernanda Lima-Costa (Oswaldo Cruz Foundation Rene Rachou Research Institute, Brazil)*; 
Hsien-Ho Lin (National Taiwan University, Taiwan)*; Xu Lin (University of Chinese Academy 
 31 
of Sciences, China)*; Allan Linneberg (Research Centre for Prevention and Health, Denmark)*; 
Lauren Lissner (University of Gothenburg, Sweden)*; Mieczyslaw Litwin (The Children's 
Memorial Health Institute, Poland)*; Jing Liu (Beijing Anzhen Hospital, Capital Medical 
University, China)*; Roberto Lorbeer (University Medicine Greifswald, Germany)*; Paulo A 
Lotufo (University of São Paulo, Brazil)*; José Eugenio Lozano (Consejería de Sanidad Junta de 
Castilla y León, Spain)*; Dalia Luksiene (Lithuanian University of Health Sciences, Lithuania)*; 
Annamari Lundqvist (National Institute for Health and Welfare, Finland)*; Nuno Lunet 
(University of Porto Medical School, Portugal)*; Per Lytsy (University of Uppsala, Sweden)*; 
Guansheng Ma (Peking University, China)*; Suka Machi (The Jikei University School of 
Medicine, Japan)*; Stefania Maggi (National Research Council, Italy)*; Dianna J Magliano (Baker 
IDI Heart and Diabetes Institute, Australia)*; Marcia Makdisse (Hospital Israelita Albert Einstein, 
Brazil)*; Reza Malekzadeh (Tehran University of Medical Sciences, Iran)*; Rahul Malhotra 
(Duke-NUS Graduate Medical School, Singapore)*; Kodavanti Mallikharjuna Rao (Indian 
Council of Medical Research, India)*; Yannis Manios (Harokopio University of Athens, Greece)*; 
Jim I Mann (University of Otago, New Zealand)*; Enzo Manzato (University of Padova, Italy)*; 
Paula Margozzini (Pontificia Universidad Católica de Chile, Chile)*; Oonagh Markey (University 
of Reading, UK)*; Pedro Marques-Vidal (Lausanne University Hospital, Switzerland)*; Jaume 
Marrugat (Institut Hospital del Mar d'Investigacions Mèdiques, Spain)*; Yves Martin-Prevel 
(Institut de Recherche pour le Développement, France)*; Reynaldo Martorell (Emory University, 
USA)*; Shariq R Masoodi (Sher-i-Kashmir Institute of Medical Sciences, India)*; Tandi E Matsha 
(Cape Peninsula University of Technology, South Africa)*; Johansson Mattias (International 
Agency for Research on Cancer, France)*; Artur Mazur (University of Rzeszow, Poland)*; Jean 
Claude N Mbanya (University of Yaoundé 1, Cameroon)*; Shelly R McFarlane (The University 
 32 
of the West Indies, Jamaica)*; Stephen T McGarvey (Brown University, USA)*; Martin McKee 
(London School of Hygiene & Tropical Medicine, UK)*; Stela McLachlan (University of 
Edinburgh, UK)*; Rachael M McLean (University of Otago, New Zealand)*; Breige A McNulty 
(University College Dublin, Ireland)*; Safiah Md Yusof (Universiti Teknologi MARA, 
Malaysia)*; Sounnia Mediene-Benchekor (University of Oran 1, Algeria)*; Aline Meirhaeghe 
(Institut National de la Santé et de la Recherche Médicale, France)*; Christa Meisinger (Helmholtz 
Zentrum München, Germany)*; Larissa L Mendes (Universidade Federal de Juiz de Fora, 
Brazil)*; Ana Maria B Menezes (Universidade Federal de Pelotas, Brazil)*; Gert BM Mensink 
(Robert Koch Institute, Germany)*; Indrapal I Meshram (Indian Council of Medical Research, 
India)*; Andres Metspalu (University of Tartu, Estonia)*; Jie Mi (Capital Institute of Pediatrics, 
China)*; Kim F Michaelsen (University of Copenhagen, Denmark)*; Kairit Mikkel (University of 
Tartu, Estonia)*; Jody C Miller (University of Otago, New Zealand)*; Juan Francisco Miquel 
(Pontificia Universidad Católica de Chile, Chile)*; J Jaime Miranda (Universidad Peruana 
Cayetano Heredia, Peru)*; Marjeta Mišigoj-Durakovic (University of Zagreb, Croatia)*; Mostafa 
K Mohamed (Ain Shams University, Egypt)*; Kazem Mohammad (Tehran University of Medical 
Sciences, Iran)*; Noushin Mohammadifard (Isfahan University of Medical Sciences, Iran)*; 
Viswanathan Mohan (Madras Diabetes Research Foundation, India)*; Muhammad Fadhli Mohd 
Yusoff (Ministry of Health, Malaysia)*; Drude Molbo (University of Copenhagen, Denmark)*; 
Niels C Møller (University of Southern Denmark, Denmark)*; Dénes Molnár (University of Pécs, 
Hungary)*; Charles K Mondo (Mulago Hospital, Uganda)*; Eric A Monterrubio (Instituto 
Nacional de Salud Pública, Mexico)*; Kotsedi Daniel K Monyeki (University of Limpopo, South 
Africa)*; Leila B Moreira (Universidade Federal do Rio Grande do Sul, Brazil)*; Alain Morejon 
(University Medical Science, Cuba)*; Luis A Moreno (Universidad de Zaragoza, Spain)*; Karen 
 33 
Morgan (RCSI Dublin, Ireland)*; Erik Lykke Mortensen (University of Copenhagen, Denmark)*; 
George Moschonis (Harokopio University of Athens, Greece)*; Malgorzata Mossakowska 
(International Institute of Molecular and Cell Biology, Poland)*; Aya Mostafa (Ain Shams 
University, Egypt)*; Jorge Mota (University of Porto, Portugal)*; Mohammad Esmaeel Motlagh 
(Ahvaz Jundishapur University of Medical Sciences, Iran)*; Jorge Motta (Gorgas Memorial 
Institute of Public Health, Panama)*; Thet Thet Mu (Ministry of Health, Myanmar)*; Maria L 
Muiesan (University of Brescia, Italy)*; Martina Müller-Nurasyid (Helmholtz Zentrum München, 
Germany)*; Neil Murphy (Imperial College London, UK)*; Jaakko Mursu (University of Eastern 
Finland, Finland)*; Elaine M Murtagh (Mary Immaculate College, Ireland)*; Kamarul Imran 
Musa (Universiti Sains Malaysia, Kota Bharu, Malaysia)*; Vera Musil (University of Zagreb, 
Croatia)*; Gabriele Nagel (Ulm University, Germany)*; Harunobu Nakamura (Kobe University, 
Japan)*; Jana Námešná (Regional Authority of Public Health, Banska Bystrica, Slovakia)*; Ei Ei 
K Nang (National University of Singapore, Singapore)*; Vinay B Nangia (Suraj Eye Institute, 
India)*; Martin Nankap (Helen Keller International, Cameroon)*; Sameer Narake (Healis 
Sekhsaria Institute for Public Health, India)*; Eva Maria Navarrete-Muñoz (CIBER en 
Epidemiología y Salud Pública, Spain)*; Martin Neovius (Karolinska Institutet, Sweden)*; Flavio 
Nervi (Pontificia Universidad Católica de Chile, Chile)*; Hannelore K Neuhauser (Robert Koch 
Institute, Germany)*; Nguyen D Nguyen (University of Pharmacy and Medicine of Ho Chi Minh 
City, Vietnam)*; Quang Ngoc Nguyen (Hanoi Medical University, Vietnam)*; Ramfis E Nieto-
Martínez (Universidad Centro-Occidental Lisandro Alvarado, Venezuela)*; Guang Ning 
(Shanghai Jiao-Tong University School of Medicine, China)*; Toshiharu Ninomiya (Kyushu 
University, Japan)*; Sania Nishtar (Heartfile, Pakistan)*; Marianna Noale (National Research 
Council, Italy)*; Teresa Norat (Imperial College London, UK)*; Davide Noto (University of 
 34 
Palermo, Italy)*; Mohannad Al Nsour (Eastern Mediterranean Public Health Network, Jordan)*; 
Dermot O'Reilly (The Queen's University of Belfast, UK)*; Angélica M Ochoa-Avilés 
(Universidad de Cuenca, Ecuador)*; Kyungwon Oh (Korea Centers for Disease Control and 
Prevention, South Korea)*; Iman H Olayan (Kuwait Institute for Scientific Research, Kuwait)*; 
Maria Teresa Anselmo Olinto (University of Vale do Rio dos Sinos, Brazil)*; Maciej Oltarzewski 
(National Food and Nutrition Institute, Poland)*; Mohd A Omar (Ministry of Health, Malaysia)*; 
Altan Onat (Istanbul University, Turkey)*; Pedro Ordunez (Pan American Health Organization, 
USA)*; Ana P Ortiz (University of Puerto Rico, Puerto Rico)*; Merete Osler (Research Center for 
Prevention and Health, Denmark)*; Clive Osmond (MRC Lifecourse Epidemiology Unit, UK)*; 
Sergej M Ostojic (University of Novi Sad, Serbia)*; Johanna A Otero (Fundación Oftalmológica 
de Santander, Colombia)*; Kim Overvad (Aarhus University, Denmark)*; Fred Michel Paccaud 
(Institute for Social and Preventive Medicine, Switzerland)*; Cristina Padez (University of 
Coimbra, Portugal)*; Andrzej Pajak (Jagiellonian University Medical College, Poland)*; 
Domenico Palli (Cancer Prevention and Research Institute, Italy)*; Alberto Palloni (University of 
Madison-Wisconsin, USA)*; Luigi Palmieri (Istituto Superiore di Sanità, Italy)*; Songhomitra 
Panda-Jonas (Ruprecht-Karls-University of Heidelberg, Germany)*; Francesco Panza (University 
of Bari, Italy)*; Winsome R Parnell (University of Otago, New Zealand)*; Mahboubeh Parsaeian 
(Non-Communicable Diseases Research Center, Iran)*; Mangesh S Pednekar (Sekhsaria Institute 
for Public Health, India)*; Petra H Peeters (University Medical Center Utrecht, The Netherlands)*; 
Sergio Viana Peixoto (Oswaldo Cruz Foundation Rene Rachou Research Institute, Brazil)*; 
Alexandre C Pereira (Heart Institute (InCor), Brazil)*; Cynthia M Pérez (University of Puerto Rico 
Medical Sciences Campus, Puerto Rico)*; Annette Peters (Helmholtz Zentrum München, 
Germany)*; Niloofar Peykari (Non-Communicable Diseases Research Center, Iran)*; Son Thai 
 35 
Pham (Vietnam National Heart Institute, Vietnam)*; Iris Pigeot (Leibniz Institute for Prevention 
Research and Epidemiology - BIPS, Germany)*; Hynek Pikhart (University College London, 
UK)*; Aida Pilav (Federal Ministry of Health, Bosnia and Herzegovina)*; Lorenza Pilotto 
(Cardiovascular Prevention Centre, Italy)*; Francesco Pistelli (University Hospital of Pisa, Italy)*; 
Freda Pitakaka (University of New South Wales, Australia)*; Aleksandra Piwonska (The Cardinal 
Wyszynski Institute of Cardiology, Poland)*; Jerzy Piwonski (The Cardinal Wyszynski Institute 
of Cardiology, Poland)*; Pedro Plans-Rubió (Public Health Agency of Catalonia, Spain)*; Bee 
Koon Poh (Universiti Kebangsaan Malaysia, Malaysia)*; Miquel Porta (Institut Hospital del Mar 
d'Investigacions Mèdiques, Spain)*; Marileen LP Portegies (Erasmus Medical Center Rotterdam, 
The Netherlands)*; Dimitrios Poulimeneas (Alexander Technological Educational Institute, 
Greece)*; Rajendra Pradeepa (Madras Diabetes Research Foundation, India)*; Mathur Prashant 
(Indian Council of Medical Research, India)*; Jacqueline F Price (University of Edinburgh, UK)*; 
Maria Puiu (University of Medicine and Pharmacy "Victor Babes", Romania)*; Margus Punab 
(Tartu University Clinics, Estonia)*; Radwan F Qasrawi (Al-Quds University, Palestine)*; 
Mostafa Qorbani (Alborz University of Medical Sciences, Iran)*; Tran Quoc Bao (Ministry of 
Health, Vietnam)*; Ivana Radic (Institute of Public Health of Vojvodina, Serbia)*; Ricardas 
Radisauskas (Lithuanian University of Health Sciences, Lithuania)*; Mahmudur Rahman 
(Institute of Epidemiology Disease Control and Research, Bangladesh)*; Olli Raitakari (Turku 
University Hospital, Finland)*; Manu Raj (Amrita Institute of Medical Sciences, India)*; Sudha 
Ramachandra Rao (National Institute of Epidemiology, India)*; Ambady Ramachandran (India 
Diabetes Research Foundation, India)*; Jacqueline Ramke (University of New South Wales, 
Australia)*; Rafel Ramos (Institut Universitari d’Investigació en Atenció Primària Jordi Gol, 
Spain)*; Sanjay Rampal (University of Malaya, Malaysia)*; Finn Rasmussen (Karolinska 
 36 
Institutet, Sweden)*; Josep Redon (University of Valencia, Spain)*; Paul Ferdinand M Reganit 
(University of the Philippines, Philippines)*; Robespierre Ribeiro (Department of Health, 
Brazil)*; Elio Riboli (Imperial College London, UK)*; Fernando Rigo (Health Center San 
Agustín, Spain)*; Tobias Floris Rinke de Wit (University of Amsterdam, The Netherlands)*; 
Raphael M Ritti-Dias (Hospital Israelita Albert Einstein, Brazil)*; Juan A Rivera (Instituto 
Nacional de Salud Pública, Mexico)*; Sian M Robinson (University of Southampton, UK)*; 
Cynthia Robitaille (Public Health Agency of Canada, Canada)*; Fernando Rodríguez-Artalejo 
(Universidad Autónoma de Madrid, Spain)*; María del Cristo Rodriguez-Perez (Canarian Health 
Service, Spain)*; Laura A Rodríguez-Villamizar (Universidad Industrial de Santander, 
Colombia)*; Rosalba Rojas-Martinez (Instituto Nacional de Salud Pública, Mexico)*; Nipa 
Rojroongwasinkul (Mahidol University, Thailand)*; Dora Romaguera (CIBEROBN, Spain)*; 
Kimmo Ronkainen (University of Eastern Finland, Finland)*; Annika Rosengren (University of 
Gothenburg, Sweden)*; Ian Rouse (Fiji National University, Fiji)*; Adolfo Rubinstein (Institute 
for Clinical Effectiveness and Health Policy, Argentina)*; Frank J Rühli (University of Zurich, 
Switzerland)*; Ornelas Rui (University of Madeira, Portugal)*; Blanca Sandra Ruiz-Betancourt 
(Instituto Mexicano del Seguro Social, Mexico)*; Andrea R V Russo Horimoto (Heart Institute 
(InCor), Brazil)*; Marcin Rutkowski (Medical University of Gdansk, Poland)*; Charumathi 
Sabanayagam (Singapore Eye Research Institute, Singapore)*; Harshpal S Sachdev (Sitaram 
Bhartia Institute of Science and Research, India)*; Olfa Saidi (Faculty of Medicine of Tunis, 
Tunisia)*; Benoit Salanave (French Institute for Health Surveillance, France)*; Eduardo Salazar 
Martinez (National Institute of Public Health, Mexico)*; Veikko Salomaa (National Institute for 
Health and Welfare, Finland)*; Jukka T Salonen (University of Helsinki, Finland)*; Massimo 
Salvetti (University of Brescia, Italy)*; Jose Sánchez-Abanto (National Institute of Health, Peru)*; 
 37 
Sandjaja (Ministry of Health, Indonesia)*; Susana Sans (Department of Health, Spain)*; Diana 
Santos (University of Lisbon, Portugal)*; Osvaldo Santos (Institute of Preventive Medicine, 
Portugal)*; Renata Nunes dos Santos (University of São Paulo, Brazil)*; Rute Santos (University 
of Porto, Portugal)*; Luis B Sardinha (University of Lisbon, Portugal)*; Nizal Sarrafzadegan 
(Isfahan University of Medical Sciences, Iran)*; Kai-Uwe Saum (German Cancer Research 
Center, Germany)*; Savvas C Savva (Research and Education Institute of Child Health, Cyprus)*; 
Marcia Scazufca (University of São Paulo, Brazil)*; Angelika Schaffrath Rosario (Robert Koch 
Institute, Germany)*; Herman Schargrodsky (Hospital Italiano de Buenos Aires, Argentina)*; 
Anja Schienkiewitz (Robert Koch Institute, Germany)*; Ida Maria Schmidt (Rigshospitalet, 
Denmark)*; Ione J Schneider (Federal University of Santa Catarina, Brazil)*; Constance Schultsz 
(University of Amsterdam, The Netherlands)*; Aletta E Schutte (MRC North-West University, 
South Africa)*; Aye Aye Sein (Ministry of Health, Thailand)*; Idowu O Senbanjo (Lagos State 
University College of Medicine, Nigeria)*; Sadaf G Sepanlou (Digestive Diseases Research 
Institute, Iran)*; Svetlana A Shalnova (Moscow State Pirigov Medical University, Russia)*; 
Jonathan E Shaw (Baker IDI Heart and Diabetes Institute, Australia)*; Kenji Shibuya (The 
University of Tokyo, Japan)*; Youchan Shin (Singapore Eye Research Institute, Singapore)*; 
Rahman Shiri (Finnish Institute of Occupational Health, Finland)*; Rosalynn Siantar (Singapore 
Eye Research Institute, Singapore)*; Abla M Sibai (American University of Beirut, Lebanon)*; 
Antonio M Silva (Federal University of Maranhao, Brazil)*; Diego Augusto Santos Silva (Federal 
University of Santa Catarina, Brazil)*; Mary Simon (India Diabetes Research Foundation, India)*; 
Judith Simons (St Vincent's Hospital, Australia)*; Leon A Simons (University of New South 
Wales, Australia)*; Michael Sjostrom (Karolinska Institutet, Sweden)*; Jolanta Slowikowska-
Hilczer (Medical University of Lodz, Poland)*; Przemyslaw Slusarczyk (International Institute of 
 38 
Molecular and Cell Biology, Poland)*; Liam Smeeth (London School of Hygiene & Tropical 
Medicine, UK)*; Margaret C Smith (University of Oxford, UK)*; Marieke B Snijder (Academic 
Medical Center of University of Amsterdam, The Netherlands)*; Hung-kwan So (The Chinese 
University of Hong Kong, China)*; Eugène Sobngwi (University of Yaoundé 1, Cameroon)*; 
Stefan Söderberg (Umeå University, Sweden)*; Moesijanti YE Soekatri (Health Polytechnics 
Institute, Indonesia)*; Vincenzo Solfrizzi (University of Bari, Italy)*; Emily Sonestedt (Lund 
University, Sweden)*; Thorkild IA Sørensen (University of Copenhagen, Denmark)*; Maroje 
Soric (University of Zagreb, Croatia)*; Charles Sossa Jérome (Institut Régional de Santé Publique, 
West Africa)*; Aicha Soumare (University of Bordeaux, France)*; Jan A Staessen (University of 
Leuven, Belgium)*; Gregor Starc (University of Ljubljana, Slovenia)*; Maria G Stathopoulou 
(INSERM, France)*; Kaspar Staub (University of Zurich, Switzerland)*; Bill Stavreski (Heart 
Foundation, Australia)*; Jostein Steene-Johannessen (Norwegian School of Sport Sciences, 
Norway)*; Peter Stehle (Bonn University, Germany)*; Aryeh D Stein (Emory University, USA)*; 
George S Stergiou (Sotiria Hospital, Greece)*; Jochanan Stessman (Hadassah University Medical 
Center, Israel)*; Jutta Stieber (Helmholtz Zentrum München, Germany)*; Doris Stöckl 
(Helmholtz Zentrum München, Germany)*; Tanja Stocks (Lund University, Sweden)*; Jakub 
Stokwiszewski (National Institute of Public Health-National Institute of Hygiene, Poland)*; 
Gareth Stratton (Swansea University, UK)*; Maria Wany Strufaldi (Federal University of São 
Paulo, Brazil)*; Chien-An Sun (Fu Jen Catholic University, Taiwan)*; Johan Sundström (Uppsala 
University, Sweden)*; Yn-tz Sung (The Chinese University of Hong Kong, China)*; Jordi Sunyer 
(Centre for Research in Environmental Epidemiology, Spain)*; Paibul Suriyawongpaisal (Mahidol 
University, Thailand)*; Boyd A Swinburn (The University of Auckland, New Zealand)*; Rody G 
Sy (University of the Philippines, Philippines)*; Lucjan Szponar (National Food and Nutrition 
 39 
Institute, Poland)*; E Shyong Tai (National University of Singapore, Singapore)*; Mari-Liis 
Tammesoo (University of Tartu, Estonia)*; Abdonas Tamosiunas (Lithuanian University of 
Health Sciences, Lithuania)*; Line Tang (Research Centre for Prevention and Health, Denmark)*; 
Xun Tang (Peking University Health Science Cente, China)*; Frank Tanser (University of 
KwaZulu-Natal, South Africa)*; Yong Tao (Peking University, China)*; Mohammed Tarawneh 
(Ministry of Health, Jordan)*; Jakob Tarp (University of Southern Denmark, Denmark)*; Carolina 
B Tarqui-Mamani (National Institute of Health, Peru)*; Anne Taylor (The University of Adelaide, 
Australia)*; Félicité Tchibindat (UNICEF, Cameroon)*; Lutgarde Thijs (University of Leuven, 
Belgium)*; Anne Tjonneland (Danish Cancer Society Research Centre, Denmark)*; Hanna K 
Tolonen (National Institute for Health and Welfare, Finland)*; Janne S Tolstrup (University of 
Southern Denmark, Denmark)*; Murat Topbas (Karadeniz Technical University, Turkey)*; 
Roman Topór-Madry (Jagiellonian University Medical College, Poland)*; Maties Torrent (IB-
SALUT Area de Salut de Menorca, Spain)*; Pierre Traissac (Institut de Recherche pour le 
Développement, France)*; Antonia Trichopoulou (Hellenic Health Foundation, Greece)*; 
Dimitrios Trichopoulou (Harvard T.H. Chan School of Public Health, USA)*; Oanh TH Trinh 
(University of Pharmacy and Medicine of Ho Chi Minh City, Vietnam)*; Atul Trivedi 
(Government Medical College, India)*; Lechaba Tshepo (Sefako Makgatho Health Science 
University, South Africa)*; Marshall K Tulloch-Reid (The University of the West Indies, 
Jamaica)*; Tomi-Pekka Tuomainen (University of Eastern Finland, Finland)*; Jaakko Tuomilehto 
(National Institute for Health and Welfare, Finland)*; Maria L Turley (Ministry of Health, New 
Zealand)*; Per Tynelius (Karolinska Institutet, Sweden)*; Themistoklis Tzotzas (Hellenic Medical 
Association for Obesity, Greece)*; Betina Thuesen H (Research Centre for Prevention and Health, 
Denmark)*; Christophe Tzourio (University of Bordeaux, France)*; Peter Ueda (Harvard T.H. 
 40 
Chan School of Public Health, USA)*; Flora AM Ukoli (Meharry Medical College, USA)*; Hanno 
Ulmer (Medical University of Innsbruck, Austria)*; Belgin Unal (Dokuz Eylul University, 
Turkey)*; Gonzalo Valdivia (Pontificia Universidad Católica de Chile, Chile)*; Susana Vale 
(University of Porto, Portugal)*; Damaskini Valvi (Harvard T.H. Chan School of Public Health, 
USA)*; Yvonne T van der Schouw (University Medical Center Utrecht, The Netherlands)*; Koen 
van Herck (Ghent University, Belgium)*; Hoang Van Minh (Hanoi Medical University, 
Vietnam)*; Irene GM van Valkengoed (Academic Medical Center of University of Amsterdam, 
The Netherlands)*; Dirk Vanderschueren (Katholieke Universiteit Leuven, Belgium)*; Diego 
Vanuzzo (Centro di Prevenzione Cardiovascolare Udine, Italy)*; Lars Vatten (Norwegian 
University of Science and Technology, Norway)*; Tomas Vega (Consejería de Sanidad Junta de 
Castilla y León, Spain)*; Gustavo Velasquez-Melendez (Universidade Federal de Minas Gerais, 
Brazil)*; Giovanni Veronesi (University of Insubria, Italy)*; WM Monique Verschuren (National 
Institute for Public Health and the Environment, The Netherlands)*; Giovanni Viegi (Italian 
National Research Council, Italy)*; Lucie Viet (National Institute for Public Health and the 
Environment, The Netherlands)*; Eira Viikari-Juntura (Finnish Institute of Occupational Health, 
Finland)*; Paolo Vineis (Imperial College London, UK)*; Jesus Vioque (Universidad Miguel 
Hernandez, Spain)*; Jyrki K Virtanen (University of Eastern Finland, Finland)*; Sophie Visvikis-
Siest (INSERM, France)*; Bharathi Viswanathan (Ministry of Health, Seychelles)*; Peter 
Vollenweider (Lausanne University Hospital, Switzerland)*; Sari Voutilainen (University of 
Eastern Finland, Finland)*; Martine Vrijheid (Centre for Research in Environmental 
Epidemiology, Spain)*; Alisha N Wade (University of the Witwatersrand, South Africa)*; Aline 
Wagner (University of Strasbourg, France)*; Janette Walton (University College Cork, Ireland)*; 
Ming-Dong Wang (Public Health Agency of Canada, Canada)*; Qian Wang (Xinjiang Medical 
 41 
University, China)*; Ya Xing Wang (Beijing Tongren Hospital, China)*; S Goya Wannamethee 
(University College London, UK)*; Nicholas Wareham (University of Cambridge, UK)*; Deepa 
Weerasekera (Ministry of Health, New Zealand)*; Peter H Whincup (St George’s, University of 
London, UK)*; Kurt Widhalm (Medical University of Vienna, Austria)*; Indah S Widyahening 
(Universitas Indonesia, Indonesia)*; Andrzej Wiecek (Medical University of Silesia, Poland)*; 
Rainford J Wilks (The University of the West Indies, Jamaica)*; Johann Willeit (Medical 
University Innsbruck, Austria)*; Bogdan Wojtyniak (National Institute of Public Health-National 
Institute of Hygiene, Poland)*; Jyh Eiin Wong (Universiti Kebangsaan Malaysia, Malaysia)*; Tien 
Yin Wong (Duke-NUS Graduate Medical School, Singapore)*; Jean Woo (The Chinese 
University of Hong Kong, China)*; Mark Woodward (University of Sydney, Australia; University 
of Oxford, UK)*; Aleksander Giwercman Wu (Lund University, Sweden)*; Frederick C Wu 
(University of Manchester, UK)*; JianFeng Wu (Shandong University of Traditional Chinese 
Medicine, China)*; Shou Ling Wu (Kailuan General Hospital, China)*; Haiquan Xu (Institute of 
Food and Nutrition Development of Ministry of Agriculture, China)*; Liang Xu (Capital Medical 
University, China)*; Uruwan Yamborisut (Mahidol University, Thailand)*; Weili Yan (Fudan 
University, China)*; Xiaoguang Yang (Chinese Center for Disease Control and Prevention, 
China)*; Nazan Yardim (Ministry of Health, Turkey)*; Xingwang Ye (University of Chinese 
Academy of Sciences, China)*; Panayiotis K Yiallouros (Cyprus University of Technology, 
Cyprus)*; Akihiro Yoshihara (Niigata University, Japan)*; Qi S You (Capital Medical University, 
China)*; Novie O Younger-Coleman (The University of the West Indies, Jamaica)*; Ahmad F 
Yusoff (Ministry of Health, Malaysia)*; Ahmad A Zainuddin (Universiti Teknologi MARA, 
Malaysia)*; Sabina Zambon (University of Padova, Italy)*; Tomasz Zdrojewski (Medical 
University of Gdansk, Poland)*; Yi Zeng (Duke University, USA)*; Dong Zhao (Beijing Anzhen 
 42 
Hospital, Capital Medical University, China)*; Wenhua Zhao (Chinese Center for Disease Control 
and Prevention, China)*; Yingfeng Zheng (Singapore Eye Research Institute, Singapore)*; 
Maigeng Zhou (Chinese Center for Disease Control and Prevention, China)*; Dan Zhu (Inner 
Mongolia Medical University, China)*; Esther Zimmermann (Bispebjerg and Frederiksberg 
Hospitals, Denmark)*; Julio Zuñiga Cisneros (Gorgas Memorial Institute of Public Health, 
Panama) 
 
 
 
 
 
 
 
  
 43 
Acknowledgements  
We thank Christina Banks, Quentin Hennocq, Dheeya Rizmie, and Yasaman Vali for assistance 
with data extraction. We thank WHO country and regional offices and World Heart Federation for 
support in data identification and access. 
 
Contributions 
ME designed the study and oversaw research. Members of the Country and Regional Data Group 
collected and reanalysed data, and checked pooled data for accuracy of information about their 
study and other studies in their country. MDC and GAS led data collection and JB led the statistical 
analysis and prepared results. Members of the Pooled Analysis and Writing Group collated data, 
checked all data sources in consultation with the Country and Regional Data Group, analysed 
pooled data, and prepared results. ME wrote the first draft of the report with input from other 
members of Pooled Analysis and Writing Group. Members of Country and Regional Data Group 
commented on draft report. 
 
Conflict of interest  
Dr. Miranda reports funding from Medtronics Foundation, outside the submitted work. 
 44 
Figure 1: Trends in age-standardised mean BMI by sex and region. See Appendix Figure 8 for 
trends by country. 
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Figure 2: Age-standardised mean BMI by sex and country in 1975 and 2014. See Appendix Table 
4 for numerical results. 
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Figure 3: Comparison of average change in age-standardised mean BMI before and after the year 
2000. Each point shows one country. A: countries in which mean BMI increased more rapidly 
after 2000 than it had before 2000; B: countries in which mean BMI increased more slowly after 
2000 than it had before 2000; C: countries in which mean BMI increased before 2000 but decreased 
after 2000; D: countries in which mean BMI decreased more rapidly after 2000 than it had before 
2000; E: countries in which mean BMI decreased more slowly after 2000 than it had before 2000; 
F: countries in which BMI decreased before 2000 but increased after 2000. 
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Figure 4: Trends in age-standardised prevalences of BMI categories by sex and region. See 
Appendix Figure 8 for results by country. 
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Figure 5: Age-standardised prevalence by sex and country in 2014 for underweight (BMI < 18.5 
kg/m2); obesity (BMI ≥ 30 kg/m2); and severe obesity (BMI ≥ 35 kg/m2). See Appendix Table 5 
for numerical results for all BMI ranges. 
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Figure 6: Trends in the number of obese (BMI ≥ 30 kg/m2) and severely obese (BMI ≥ 35 kg/m2) 
people, by region.  
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Figure 7: Ten countries with the largest number of underweight (BMI < 18.5 kg/m2), obese (BMI 
≥ 30 kg/m2), and severely obese (BMI ≥ 35 kg/m2) people in 1975 and 2014. Colours for each 
country indicate its region, using the same colour scheme as in Figure 3. 
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